Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza for Pediatric Cataract Surgery
NCT04539548Phase 3Completed
- Sponsor
- Ocular Therapeutix
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in post-operative ocular pain, post-operative ocular inflammation, sponsored by Ocular Therapeutix. Started Sep 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
post-operative ocular painpost-operative ocular inflammation
Beyond the preview
Go deeper on NCT04539548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539548.